Preclinical evaluation of SMM ‐189, a cannabinoid receptor 2‐specific inverse agonist-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Preclinical evaluation of SMM ‐189, a cannabinoid receptor 2‐specific inverse agonist

Published:2015-07-06 Issue:4 Volume:3 Page:
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol Res Perspect

Author:

Presley Chaela¹,Abidi Ammaar¹,Suryawanshi Satyendra¹,Mustafa Suni¹,Meibohm Bernd¹,Moore Bob M.¹

Affiliation:

1. Department of Pharmaceutical Sciences College of Pharmacy University of Tennessee Health Science Center Memphis Tennessee

Funder

The University of Tennessee Health Science Center

College of Pharmacy

UTHSC Neuroscience Institute

Endece LLC

National Institutes of Health

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.159

Reference71 articles.

1. The Cannabinoid CB2 Receptor as a Target for Inflammation-Dependent Neurodegeneration

2. Increased Expression of MIP-1α and MIP-1β mRNAs in the Brain Correlates Spatially and Temporally with the Spongiform Neurodegeneration Induced by a Murine Oncornavirus

3. Design and synthesis of novel tri-aryl CB2 selective cannabinoid ligands

4. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis

5. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Type 2 cannabinoid receptor expression on microglial cells regulates neuroinflammation during graft-versus-host disease;Journal of Clinical Investigation;2024-04-25

2. Modulation of cannabinoid receptor 2 alters neuroinflammation and reduces formation of alpha-synuclein aggregates in a rat model of nigral synucleinopathy;2023-08-27

3. MICROGLIAL CELL EXPRESSION OF THE TYPE 2 CANNABINOID RECEPTOR REGULATES IMMUNE-MEDIATED NEUROINFLAMMATION;2023-08-14

4. CB2 receptor in the CNS: From immune and neuronal modulation to behavior;Neuroscience & Biobehavioral Reviews;2023-07

5. Exploring the Therapeutic Potential of Cannabinoid Receptor Antagonists in Inflammation, Diabetes Mellitus, and Obesity;Biomedicines;2023-06-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3